太龙药业: 公司章程

General Provisions - The company is established as a joint-stock limited company in accordance with the Company Law and other relevant regulations [2] - The registered capital of the company is RMB 573.886283 million, and the paid-in capital is also RMB 573.886283 million [2][3] - The company is intended to exist permanently as a joint-stock limited company [3] Business Objectives and Scope - The company's mission is to safeguard health, with quality as the foundation, market orientation, and a focus on efficiency, aiming for high-quality development and ensuring shareholder rights [5] - The business scope includes the production and sale of pharmaceuticals, health foods, pre-packaged foods, medicinal plants, medical devices, sanitary products, cosmetics, consulting services, and technology services [5] Party Organization - The company has established a party organization that plays a leading and political core role, ensuring the implementation of national policies and strategies [4][6] Share Issuance - The company's shares are issued in the form of stocks, adhering to principles of openness, fairness, and justice [8] - The total number of shares issued by the company is 573.886283 million, all of which are ordinary shares [7] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, supervision of company operations, and access to company documents [11][36] - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not abuse their rights to harm the company or other shareholders [18][42] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting occurring within six months after the end of the previous fiscal year [50] - Shareholder meetings require a quorum and must follow specific procedures for proposals, notifications, and voting [66][82] Decision-Making and Voting - Ordinary resolutions require a simple majority, while special resolutions require two-thirds of the voting rights present [82][84] - The company must disclose the results of votes affecting minority investors separately [85]